[go: up one dir, main page]

MXPA05006450A - Nuevo derivado de 2,4-diamino-1,3,5-triazina. - Google Patents

Nuevo derivado de 2,4-diamino-1,3,5-triazina.

Info

Publication number
MXPA05006450A
MXPA05006450A MXPA05006450A MXPA05006450A MXPA05006450A MX PA05006450 A MXPA05006450 A MX PA05006450A MX PA05006450 A MXPA05006450 A MX PA05006450A MX PA05006450 A MXPA05006450 A MX PA05006450A MX PA05006450 A MXPA05006450 A MX PA05006450A
Authority
MX
Mexico
Prior art keywords
diamino
novel
triazine derivative
general formula
acceptable salt
Prior art date
Application number
MXPA05006450A
Other languages
English (en)
Inventor
Kita Toshiko
Original Assignee
Hamari Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamari Chemicals Ltd filed Critical Hamari Chemicals Ltd
Publication of MXPA05006450A publication Critical patent/MXPA05006450A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/10—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un antibacteriano caracterizado por contener como un ingrediente activo ya sea un compuesto representado por la formula general (1) o una sal farmacologicamente aceptable del mismo.
MXPA05006450A 2002-12-17 2003-12-16 Nuevo derivado de 2,4-diamino-1,3,5-triazina. MXPA05006450A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002365927 2002-12-17
JP2003363820 2003-10-23
PCT/JP2003/016131 WO2004054989A1 (ja) 2002-12-17 2003-12-16 新規２，４−ジアミノ−１，３，５−トリアジン誘導体

Publications (1)

Publication Number Publication Date
MXPA05006450A true MXPA05006450A (es) 2005-08-19

Family

ID=32599275

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05006450A MXPA05006450A (es) 2002-12-17 2003-12-16 Nuevo derivado de 2,4-diamino-1,3,5-triazina.

Country Status (11)

Country Link
US (1) US7622469B2 (es)
EP (1) EP1574503B1 (es)
JP (1) JP4391422B2 (es)
KR (1) KR101027366B1 (es)
AU (1) AU2003289375A1 (es)
BR (1) BRPI0317188A8 (es)
CA (1) CA2510468C (es)
ES (1) ES2403141T3 (es)
MX (1) MXPA05006450A (es)
NZ (1) NZ540972A (es)
WO (1) WO2004054989A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2610829A1 (en) * 2005-06-14 2006-12-28 Schering Corporation The preparation and use of compounds as aspartyl protease inhibitors
FR2896161B1 (fr) * 2006-01-13 2008-04-04 Merck Sante Soc Par Actions Si Utilisation de derives de triazines pour fabriquer un medicament ayant un effet cicatrisant ou angiogenique.
DE102007054416A1 (de) 2007-11-13 2009-05-14 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5- Triazin-Derivaten für die Behandlungen von Erkrankungen, die mit dem Insulinresistenz-Syndrom assoziiert sind
DE102008007314A1 (de) 2008-02-02 2009-08-06 Merck Patent Gmbh Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-triazinderivaten
CA2725011A1 (en) * 2008-05-23 2009-11-26 Poxel Sas Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives
JPWO2010024225A1 (ja) * 2008-08-25 2012-01-26 浜理薬品工業株式会社 新規ジヒドロトリアジン誘導体
US11465989B2 (en) 2014-04-17 2022-10-11 ImmunoMet Therapeutics, Inc. Guanidine compounds and use thereof
KR102216701B1 (ko) 2014-11-20 2021-02-18 이뮤노메트테라퓨틱스 인코포레이티드 바이구아나이드 화합물 및 이의 용도
DE102018220631A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
DE102018220624A1 (de) * 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
CN112642410A (zh) * 2020-12-01 2021-04-13 中国工程物理研究院核物理与化学研究所 一种用于水体中铀提取的抗菌聚合物纤维及其制备方法
DE102023201122A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Antimikrobiell wirksames Produkt
DE102023201126A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Dihydrotriazinverbindung sowie Zusammensetzung zur Anwendung in der Podologie, bei der Prophylaxe und/oder Behandlung von Fußerkrankungen, der Behandlung von Tätowierungen und/oder Tätowierungswunden sowie der Behandlung eines Piercings und/oder von Piercing-Wunden
DE102023201127A1 (de) 2023-02-10 2024-08-14 B. Braun Melsungen Aktiengesellschaft Medizinprodukt und Verfahren zur Herstellung des Medizinprodukts

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168519A (en) * 1961-10-17 1965-02-02 American Cyanamid Co 1-alkylphenyl-2, 2-di lower alkyl-4, 6-diimino-hexahydro-s-triazines
US3287366A (en) * 1963-12-24 1966-11-22 American Cyanamid Co Novel 1, 2-dihydro-s-triazines
US3287365A (en) * 1963-12-24 1966-11-22 American Cyanamid Co Novel dihydro-s-triazines and method of preparation
DE1620178A1 (de) * 1965-12-03 1970-03-12 Ruhrchemie Ag Verfahren zur Herstellung von Aminoalkylamino-s-triazinen
JPS4541591B1 (es) * 1967-12-11 1970-12-26
US5565451A (en) * 1994-09-15 1996-10-15 Fmc Corporation 1-substituted-2, 4-diamino-6, 6-dialkyl-1, 6-dihydro-1, 3, 5-triazines as insecticides
WO1999001442A1 (en) 1997-07-02 1999-01-14 Zeneca Limited Triazine derivatives and their use as antibacterial agents
EP1135375B1 (en) * 1998-12-01 2005-11-09 Bayer CropScience K.K. Substituted 1,3,5-triazines as herbicides
FR2804113B1 (fr) 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
ES2423800T3 (es) * 2003-03-28 2013-09-24 Novartis Vaccines And Diagnostics, Inc. Uso de compuestos orgánicos para la inmunopotenciación

Also Published As

Publication number Publication date
HK1076816A1 (en) 2006-01-27
ES2403141T8 (es) 2013-06-21
WO2004054989A1 (ja) 2004-07-01
JP4391422B2 (ja) 2009-12-24
KR101027366B1 (ko) 2011-04-11
CA2510468A1 (en) 2004-07-01
EP1574503B1 (en) 2013-03-13
US7622469B2 (en) 2009-11-24
CA2510468C (en) 2011-01-04
BRPI0317188A2 (pt) 2005-11-01
JPWO2004054989A1 (ja) 2006-04-20
BRPI0317188A8 (pt) 2018-05-08
EP1574503A1 (en) 2005-09-14
EP1574503A4 (en) 2008-06-25
NZ540972A (en) 2009-03-31
KR20050085720A (ko) 2005-08-29
ES2403141T3 (es) 2013-05-14
AU2003289375A1 (en) 2004-07-09
US20060154928A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
MY126559A (en) Fungicidal 2-methoxybenzophenones
IL158485A (en) Spiropyrazole compounds
SG77195A1 (en) Fungicidal 2-methoxybenzophenones
EP0630898A4 (en) MEDICINE FOR THROMBOZYTOPENIA.
MY132698A (en) Herbicidal composition
EP0711768A4 (en) BENZIMIDAZOLE DERIVATIVES
IL157254A0 (en) N-substituted nonaryl-heterocyclic nmda/mr2b antagonists
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
GB0124627D0 (en) Novel compounds
SG44794A1 (en) Novel peptide derivatives
IL190643A0 (en) Novel dihydropseudoerythromycin derivatives
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
EP1704856A4 (en) PROTEIN INHIBITOR OF THE HSP90 FAMILY
MXPA05006450A (es) Nuevo derivado de 2,4-diamino-1,3,5-triazina.
AU4249700A (en) Hydroxamic acid derivative
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
BG104447A (en) Biphenylamidine derivatives
MXPA03009602A (es) Analogos de nociceptina.
EP1026162A4 (en) ANTI-RHUMATISMAL AGENT
MXPA04007048A (es) Derivados de amidoacetonitrilo.
EP1043311A4 (en) BIPHENYLAMIDINE DERIVATIVES
IL157440A0 (en) Triazole derivatives and pharmaceutical compositions containing the same
MXPA05011521A (es) Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
AU2001282238A1 (en) Dihydroporphyrin derivatives and their uses
TW200420561A (en) Antimicrobial 1-aryl dihydropyridone compounds

Legal Events

Date Code Title Description
FG Grant or registration